img
Welcome to Biotechgate, your AI-guided life sciences intelligence platform.
Company Profile Preview
Company logo

Insilico Medicine

Headquarters
Cambridge, USA
See full record
Company
Therapeutics
Technologies
Clinical trials
License agreements
Financing rounds
Management
Financials
Reports & Forecasts

Main Sector

Biotechnology - Therapeutics and Diagnostics

Subsectors

Antibodies
Small molecules

Indications

Neoplasms / cancer / oncology
Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
Endocrine, nutritional and metabolic diseases / endocrinology
Diseases of the nervous system / neurology
Cardiovascular / cardiology
Respiratory / pulmonology
Digestive system / gastroenterology
Genitourinary system / Urology
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Products

In development: 20

Description

Insilico Medicine is a biotechnology company that uses artificial intelligence (AI) and machine learning (ML) to accelerate drug discovery and development. The company's proprietary AI platforms, including Pharma.AI and the Chemistry42 generative chemistry engine are designed to identify novel targets, generate new drug candidates, and optimize molecules with high efficiency. The company's product ISM5411 is a gut-restricted small-molecule prolyl hydroxylase (PHD) inhibitor, that enhances the...

 

Log in to see full record »

No account yet?

Try Biotechgate now - learn about subscription plans and pricing!
Learn more Request a demo
© 2026 Venture Valuation
Terms of Use & Privacy Policy